CCCC vs REG · rev $35.6M vs P/E 34, $12.93B cap
C4 Therapeutics Inc (CCCC) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
REG does not have a complete income-statement cache yet.
CCCC currently screens at market cap $425.7M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the CCCC and REG stock pages for the full models.
Not investment advice.